A safety evaluation of allogeneic freeze-dried platelet-rich plasma or conditioned serum compared to autologous frozen products equivalents in equine healthy joints

BACKGROUND: Hemoderivatives such as autologous conditioned serum (ACS) and platelet-rich plasma (PRP) have been used as potential disease-modifying therapies in musculoskeletal disorders such as osteoarthritis (OA). These therapies are based on the delivery of multiple growth factors and anti-inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbin, Livia Camargo, Contino, Erin K., Olver, Christine S., Frisbie, David D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014566/
https://www.ncbi.nlm.nih.gov/pubmed/35436878
http://dx.doi.org/10.1186/s12917-022-03225-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014566/
https://www.ncbi.nlm.nih.gov/pubmed/35436878
http://dx.doi.org/10.1186/s12917-022-03225-4

Ejemplares similares